Author Archives: Lee Jackson

analysis

4 Most Oversold S&P 500 Stocks Could Have Big Upside Potential

One thing that always makes for a good rule of thumb when buying stocks is to look for solid companies with good upside potential and products or services, and where ...
Read Full Story »
American flags

Worried About Brexit? Four Companies to Buy With Almost 100% U.S. Business

A rally on Tuesday and strength on Wednesday feels like a welcome relief after two very depressing trading sessions. Still, one thing seems to be assured. The British exit, hence Brexit, from ...
Read Full Story »
dividends

Jefferies Loves Top Buy Rated Stocks Yielding 8% and More

Most investors know that logically buying the U.S. 30 year Treasury bond at a 2.26% yield makes little sense. Ditto for a 10-year yield under 1.50%. This almost feels particularly ...
Read Full Story »
home for sale

Large Biotech and Tech Highlight Insider Selling: Applied Materials, Celgene, Cisco Systems, Palo Alto, Delphi and More

What a wild and crazy week for investors. The stock market volatility index jumped up and down as the Brexit decision was finally answered. With the quarter coming to an end, ...
Read Full Story »
Currency

Forget Brexit, Jefferies Says Buy These 3 Compelling Value Companies Now

The week of June 24 was given a serious blow by the unexpected Brexit vote. Yes, Britain voted to leave the European Union. But, some companies here in the United ...
Read Full Story »
white pills

J.P. Morgan Very Positive on 3 Battered Specialty Pharmaceutical Stocks

Ever since the infamous Hillary Clinton tweet about pharmaceutical drug pricing, the biotech and specialty pharmaceutical stocks have taken a huge beating. In some cases, the markets have knocked valuations ...
Read Full Story »
graph

A Biotech and a Medical Device Stock, Each With Massive Upside Potential

Long-time aggressive investors know that biotechnology stocks can offer huge upside and also can get absolutely hammered, and in some cases even go out of business. Needless to say the ...
Read Full Story »
choose happiness

Credit Suisse Loves These 3 High-Yielding MLPs Now

Any way you slice it, the energy run up from the lows has been outstanding, and investors who had the courage to buy back in January and February have been well ...
Read Full Story »
high voltage post

Blue Chips Dominate Jefferies Value Stocks to Buy

One way or another, the Brexit decision will be settled soon, and investors can start to worry about other issues that will influence the direction of the stock market. At ...
Read Full Story »
Pumpjack

Merrill Lynch Raises Price Targets on Top Buy-Rated Energy and MLP Stocks

With the spot price of oil holding its own, and many strategists and economists positive on gross domestic product growth in the second half, there is a good chance that ...
Read Full Story »
Federal Reserve

The Fed Has No Cred: Buy These 4 Big Dividend Stocks Now

One month ago, it was all about an improving economy and jobs picture. Then the horrible May nonfarm payroll numbers came out, and quickly all bets were off. No June ...
Read Full Story »
Test tubes

Biotechs Highlight Jefferies 4 Top Growth Stocks to Buy

With the first days of summer, we usually see a slowdown on Wall Street as volumes, along with overall investor interest, drops in favor of vacations and summer fun. That ...
Read Full Story »
investing

4 Large US Dividend-Paying Small Caps for Big Second-Half Gains

What a difference a couple of days can make as the stock market rallied big on the worries of the Brexit becoming much less of a factor as polls and ...
Read Full Story »
Shanghai

Top Analyst Loves 2 Top Blue Chips With Big China Exposure

Any way you slice it, doing business in China is huge, and for one simple reason, the huge population. For years American companies have slowly but surely been making progress ...
Read Full Story »
forest fire

4 Red-Hot Biotech Stocks With Over 100% Upside Potential

Long-time aggressive investors know that biotechnology stocks can offer huge upside and also can get absolutely hammered, and in some cases go out of business. Needless to say, the biotech ...
Read Full Story »